Navigation Links
Blocking cell movement for cancer, MS treatment
Date:2/10/2010

University of Adelaide researchers in Australia are finding new ways to block the movement of cells in the body which can cause autoimmune diseases and the spread of cancer.

Led by Professor of Immunology Shaun McColl, the researchers have identified molecular "receptors" on the surface of cells which are involved in helping cells migrate to sites where they can cause disease.

"A number of diseases like cancer and autoimmune diseases, such as multiple sclerosis and arthritis, involve the inappropriate migration of cells," says Professor McColl.

"Our research shows that these receptors which help the cells migrate can be blocked pharmacologically, preventing the cell migration which causes the disease."

The researchers have identified a number of such receptors in multiple sclerosis and have developed potential therapeutic drugs that could control this disease, and other autoimmune diseases.

They are also in the process of identifying receptors on the surface of metastatic cancer cells.

"These are exciting research outcomes and will offer new treatments for these diseases which affect millions of people," says Professor McColl.


'/>"/>

Contact: Professor Shaun McColl
shaun.mccoll@adelaide.edu.au
61-414-303-425
University of Adelaide
Source:Eurekalert

Page: 1

Related biology news :

1. Caltech scientists show why anti-HIV antibodies are ineffective at blocking infection
2. U-M ballast-free ship could cut costs while blocking aquatic invaders
3. Ohio scientists develop blue-blocking glasses to improve sleep and ADHD symptoms
4. Study finds blocking angiogenesis signaling from inside cell may lead to serious health problems
5. Research finds water movements can shape fish evolution
6. Step forward for nanotechnology: Controlled movement of molecules
7. NOAA scientists map fish habitat and movements at Grays Reef Marine Sanctuary
8. Abnormal brain circuits may prevent movement disorder
9. Protein regulates movement of mitochondria in brain cells
10. Resilin springs simplify the control of crustacean limb movements
11. Effects of maternal exercise on fetal breathing movements
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:11/30/2016)... CHICAGO , Nov. 30, 2016  higi ... a new partnership initiative targeting national brands, industry ... and reward their respective audiences for taking steps ... Since its inception in 2012, higi has built ... US, impacting over 38 million people who have ...
(Date:11/29/2016)... France , November 29, 2016 Nearly one ... Continue Reading ... ... is part of an efficient Identity Management. (PRNewsFoto/DERMALOG Identification Systems) ... DERMALOG is Germany's largest Multi-Biometric supplier: ...
(Date:11/22/2016)... , November 22, 2016 According to the ... IRIS, Palm Print, Face, Vein, Signature, Voice), Multi-Factor), Component (Hardware and Software), ... published by MarketsandMarkets, the market is expected to grow from USD 10.74 ... CAGR of 16.79% between 2016 and 2022. ... ...
Breaking Biology News(10 mins):
(Date:12/8/2016)... , Dec. 8, 2016  Partnering to fuel ... Ben Franklin Technology Partners of Southeastern Pennsylvania ... ("IHG"), the parent company of Independence Blue Cross; and ... announced their intentions for a $6 million funding initiative ... healthcare startups. Responding to a burgeoning economic ...
(Date:12/7/2016)... ... 2016 , ... ACEA Biosciences, Inc. presented today updated efficacy ... for its lead drug candidate, AC0010, at the World Conference on Lung Cancer ... the safety, antitumor activity, and recommended phase II dosage of AC0010 in T790M-postitive ...
(Date:12/7/2016)... ... December 07, 2016 , ... ... it has become a Wonderware Certified System Integrator Partner. Huffman Engineering is ... Electric Software. , “The System Integrator Partner certification gives customers confidence that our ...
(Date:12/7/2016)... , Dec. 7, 2016 /PRNewswire/ - OncoQuest ... development and commercialization of immunotherapeutic products for the ... entered into an Antibody Manufacturing Development Program with ... , USA) for its oregovomab antibody product. Supported ... Phase IIb clinical study in ovarian cancer patients, ...
Breaking Biology Technology: